The epidemiologic-clinical correlation at 170 patients of hepatitis virosa (VH) indicated the following:
It is intensify the sessional frequency of ill patients with the evident increase about Jun-August (10.58), and with the extreme top in the course of November (17.64).
The dominant represent is still HBsAg-negative patients with 65.89%. Potentially inoculations (post-operative, after intervention, after injection) are 39.65% of the all number HBsAg-positive patients, but at other patients of this group the inoculation moment isn't known.
About HBsAg-positive patients the village is represented with 63.79%. About HBsAg-negative group prevails the town' inhabitants with 76.78%.
The high represent of HBsAg-positive is constituted very much at workers 31.3% and house-wife with 18.96%. About groups, we make with patient's years, the group about 16-25 year is most delicated.
The clinical and biochemical characteristic points at most difficult form of illness at B-virus hepatitis influence about which the length of hospitalization with average is 30.56 days, but about HBsAg-negative group the same is 28.18 days.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
The Medicinska Misla applies the Creative Commons Attribution License (CCAL) to all works we publish (read the human-readable summary or the full license legal code). Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in Medicinska Misla journal, so long as the original authors and source are cited. No permission is required from the authors or the publishers.
In most cases, appropriate attribution can be provided by simply citing the original article (e.g. Gogusev J, Chretien Y, Droz D. Aberrant Expression of Polycystin-1 in Renal Cell Tumors. Maced J Med Sci. 2008;1(1):11-16. doi:10.3889/MJMS.1857-5773.2008.0004). If the item you plan to reuse is not part of a published article (e.g. a featured issue image), then please indicate the originator of the work, and the volume, issue and date of the journal in which the item appeared. For any reuse or redistribution of a work, you must also make clear the license terms under which the work was published.
This broad license was developed to facilitate open access to, and free use of, original works of all types. Applying this standard license to your own work will ensure your right to make your work freely and openly available. Learn more about open access. For queries about the license, please contact us.